-
A prognostic biomarker developed using deep learning with H&E sections stratified patients with stage II or III CRC into sufficiently distinct prognostic groups that potentially could be used to guide selection of adjuvant treatment: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32998-8/fulltext?rss=yes …
#CRCSM -
Patients with metastatic colorectal cancer treated with the combination of onvansertib plus FOLFIRI had a 100% clinical benefit rate at 8 weeks by radiographic response. https://www.targetedonc.com/news/onvansertib-triplet-shows-promise-in-krasmutant-metastatic-colorectal-cancer …
#crcsm -
Steep Increase Seen in Incidence of CRC From Age 49 to 50 Years http://ow.ly/roI330qeWtu
#crcsm -
On
#WorldCancerDay
we really need to support more #research & engage in
biomarker driven #clinicaltrials. Advances for many of these cancers is coming for subsets. Cancers are heterogeneous
. One size fits all approach less likely to be successful. #CRCSM#PANCSM#HPBCSMpic.twitter.com/8a5KDLtagN
-
It is hard for me to understand such result cetuximab in
#patients with resectable#colorectal liver metastasis (New EPOC) do worse: long-term results @TheLancetOncol#crcsm#colorectalcancerhttps://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30798-3/fulltext … -
Last day for taking this survey on CIPN is tomorrow. Your opportunity to influence decision-making about CIPN. Very simple process and very small survey. Don't forget to do this..
@FightCRC@CCAlliance#crcsm https://twitter.com/manjuggm/status/1223996889114214400 … -
Also it is 71 degrees here in San Antonio and we are hiring


#crcsm#hcc#gerionchttps://twitter.com/DrSukeshiArora/status/1224487618131505152 …
-
Dr. Lenz “The incredible complete response rates & overall response rates seen are never seen with chemotherapy, & it’s very well tolerated, so if I have a choice, I would start with nivolumab-ipilimumab in 1st-line
#MSI -H...”#CRCSM from ASCO#GI20https://www.mdedge.com/hematology-oncology/article/216373/gastroenterology/dual-immunotherapy-goes-distance-msi-h … -
Colorectal cancer survival outcomes better for private hospital patients (in South Australia). ... this would appear to support earlier study from Victoria.
@thelimbiconc#crcsm https://thelimbic.com/oncology/colorectal-cancer-survival-outcomes-better-for-private-hospital-patients/ … -
Circulating Epigenetic Biomarkers for Detection of Recurrent
#ColorectalCancer http://ow.ly/hna030qcJe2#crcsm -
(EPOC): more is not always better. Cetuximab in the preoperative setting is a disadvantageous to survival. The question is why?
#GIonc#Crcsm https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30798-3/fulltext … -
Overall survival data from the New EPOC trial just published at
@TheLancetOncol.#lancet#crcsm#colorectalcancer#cancer#cancerresearch#clinicaltrials#science https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30798-3/fulltext … -
CARDS FOR JAYDEN! This 11-year-old boy is facing colon cancer. He will have surgery Feb. 11 at UNC Children’s. Send cards to Jayden Oakes, C/O Joe Bullock, 55 Bullock Lane, Durham, N.C. 27713 Let Jayden know we support him!
#NeverAlone#CRCSM pic.twitter.com/Fgu6MgZsQe
-
Thanks for the discussion..We have some pts withChek2 germ-line mutations in @COLONTOWN
#crcsm https://twitter.com/pashtoonkasi/status/1223107237607919619 … -
-
Eyal Meiri, MD, on Pembrolizumab in Colorectal Cancer: Results From the TAPUR Study https://www.ascopost.com/videos/2020-gastrointestinal-cancers-symposium/eyal-meiri-on-pembrolizumab-in-colorectal-cancer/ …
#crcsm#oncology#cancer#GI20pic.twitter.com/Y8iWk6GYdL
-
Congrats Colorado advocates, what a mile-high win! (Sorry, couldn’t resist.)
#crcadvocacy#crcsm https://twitter.com/crcadvocacy/status/1222911328760799232 …
-
When will the OS data be available? As someone who had 3m Capox for Stage 3b Rectal cancer, I am curious..
#crcsm -
very patient friendly paper re NTRK fusion treatment in
#CRCSM#colorectalcancer. Now, the question, is... where do we find them... MSI or immunotherapy groups, best guess.@LizCancerHealthhttps://twitter.com/cancerhealthmag/status/1222688269269446657 …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
platinum-based chemotherapy.
